Literature DB >> 10453865

Proportion of community-acquired pneumonia cases attributable to tobacco smoking.

J Almirall1, C A González, X Balanzó, I Bolíbar.   

Abstract

STUDY
OBJECTIVES: To assess the population-attributable risk (PAR) of smoking and the effect of tobacco smoking on the development of community-acquired pneumonia (CAP) in adults.
DESIGN: A population-based case-control study. Information on history of smoking and other risk factors was obtained by a questionnaire administered by interview.
SETTING: Mixed residential-industrial area having 74,610 adult inhabitants in Barcelona, Spain. PARTICIPANTS: Two hundred five male and female patients (age, 15 to 74 years old) with CAP diagnosed between 1993 and 1995. They were matched to 475 control subjects randomly selected from the municipal census.
RESULTS: Smoking any type of tobacco had an odds ratio (OR) of CAP of 2.0 for ever smokers (95% confidence interval [CI], 1.24 to 3.24); 1.88 for current smokers (95% CI, 1.11 to 3.19); and 2.14 for ex-smokers (95% CI, 1.26 to 3.65). A positive trend for increased risk of CAP was observed for an increase in the duration of the habit, the average number of cigarettes smoked daily, and cumulative cigarette consumption. Former smokers had a 50% reduction in the OR 5 years after the cessation of smoking. The risk of CAP attributable to the consumption of any type of tobacco in this population was 32.4% of cases (95% CI, 14.8 to 50.1%). In subjects without a history of COPD, the PAR of tobacco was 23.0% (95% CI, 3.3 to 42.7%).
CONCLUSION: This study gives better quantitative and qualitative evidence about the effects of tobacco smoking on the occurrence of pneumonia in the adult community.

Entities:  

Mesh:

Year:  1999        PMID: 10453865     DOI: 10.1378/chest.116.2.375

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  47 in total

1.  Antibiotic prescribing and admissions with major suppurative complications of respiratory tract infections: a data linkage study.

Authors:  Paul Little; Louise Watson; Stephen Morgan; Ian Williamson
Journal:  Br J Gen Pract       Date:  2002-03       Impact factor: 5.386

2.  Second-generation antipsychotic medications and risk of pneumonia in schizophrenia.

Authors:  Chian-Jue Kuo; Shu-Yu Yang; Ya-Tang Liao; Wei J Chen; Wen-Chung Lee; Wen-Yi Shau; Yao-Tung Chang; Shang-Ying Tsai; Chiao-Chicy Chen
Journal:  Schizophr Bull       Date:  2012-01-26       Impact factor: 9.306

3.  C-rac-king the Code of Smoke-induced Pneumonia Susceptibility.

Authors:  Lee J Quinton
Journal:  Am J Respir Crit Care Med       Date:  2018-11-15       Impact factor: 21.405

Review 4.  The convergence of the global smoking, COPD, tuberculosis, HIV, and respiratory infection epidemics.

Authors:  Richard N van Zyl-Smit; Laurence Brunet; Madhukar Pai; Wing-Wai Yew
Journal:  Infect Dis Clin North Am       Date:  2010-09       Impact factor: 5.982

5.  Occupational disease and workers' compensation: coverage, costs, and consequences.

Authors:  J Paul Leigh; John A Robbins
Journal:  Milbank Q       Date:  2004       Impact factor: 4.911

Review 6.  Chronic obstructive pulmonary disease (COPD): evaluation from clinical, immunological and bacterial pathogenesis perspectives.

Authors:  Daniel J Hassett; Michael T Borchers; Ralph J Panos
Journal:  J Microbiol       Date:  2014-03-01       Impact factor: 3.422

Review 7.  Community-acquired pneumonia.

Authors:  Mark Loeb
Journal:  BMJ Clin Evid       Date:  2008-07-17

8.  Pharmacotherapy and the risk for community-acquired pneumonia.

Authors:  Jen-Tzer Gau; Utkarsh Acharya; Salman Khan; Victor Heh; Lona Mody; Tzu-Cheg Kao
Journal:  BMC Geriatr       Date:  2010-07-06       Impact factor: 3.921

9.  Hyperleptinemia is associated with impaired pulmonary host defense.

Authors:  Niki D J Ubags; Renee D Stapleton; Juanita H J Vernooy; Elianne Burg; Jenna Bement; Catherine M Hayes; Sebastian Ventrone; Lennart Zabeau; Jan Tavernier; Matthew E Poynter; Polly E Parsons; Anne E Dixon; Matthew J Wargo; Benjamin Littenberg; Emiel F M Wouters; Benjamin T Suratt
Journal:  JCI Insight       Date:  2016-06-02

10.  Susceptibility to Childhood Pneumonia: A Genome-Wide Analysis.

Authors:  Lystra P Hayden; Michael H Cho; Merry-Lynn N McDonald; James D Crapo; Terri H Beaty; Edwin K Silverman; Craig P Hersh
Journal:  Am J Respir Cell Mol Biol       Date:  2017-01       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.